Liabilities / Assets
100th percentile
Higher debt load relative to assets than 100% of similar nonprofits.
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
18.11x
Liabilities / Revenue
80th percentile
Higher debt load relative to revenue than 80% of similar nonprofits.
Net Margin
8th percentile
Higher net margin than 8% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
Score unavailable
No earlier valid filing was available within the previous three public years.
Revenue Growth
Score unavailable
No earlier valid filing was available within the previous three public years.
Balance Sheet
Assets
$15,800
No earlier filing loaded for comparison.
Net Assets
-$270,309
No earlier filing loaded for comparison.
Liabilities
$286,109
No earlier filing loaded for comparison.
Revenue And Expenses
Revenue
$720,713
No earlier filing loaded for comparison.
Expenses
$991,022
No earlier filing loaded for comparison.
Net Income
-$270,309
No earlier filing loaded for comparison.
Historical Trend
Filing Detail Status
This 2013 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2013 to Dec 31, 2013
Mission and Program Overview
Mission
Transpoc cultivates open collaboration among a wide range of oncology drug discovery organizations, including academic and medical institutions, emerging drug discovery companies, large biopharmaceutical corporations and disease-based foundations.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2013 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $15,800
- Liabilities
- $286,109
- Net assets
- -$270,309
- Revenue
- $720,713
- Expenses
- $991,022
- Net income
- -$270,309